Search clinical trials for: Botulinum Toxins, Type A
Total 495965 results
-
IpsenCompleted
-
IpsenCompletedMuscle Spasticity | Cerebrovascular AccidentHong Kong, Thailand, Malaysia, Philippines, Singapore
-
IpsenCompletedLow Back PainKorea, Republic of
-
Brazilan Center for Studies in DermatologyCompletedSun-induced WrinklesBrazil
-
Jamie Bartley, DOCompleted
-
AllerganCompletedLateral Canthal Lines | Crow's Feet LinesKorea, Republic of
-
Daewoong Pharmaceutical Co. LTD.CompletedBlepharospasmKorea, Republic of
-
NYU Langone HealthAllerganCompletedStroke With HemiparesisUnited States
-
Kaohsiung Medical UniversityUnknown
-
Assistance Publique - Hôpitaux de ParisAllerganCompletedCOMPARISON BETWEEN GROUP TREATED WITH BOTULINUM TOXIN AND PLACEBOFrance
-
AllerganCompletedMasseter Muscle HypertrophyTaiwan, Australia, Canada
-
Lille Catholic UniversityAllerganUnknownJoint Diseases | Magnetic Resonance Imaging | Knee | TherapeuticsFrance
-
University Hospital, BordeauxIpsenUnknownTendinopathy | Groin InjuryFrance
-
Solstice NeurosciencesCompleted
-
Solstice NeurosciencesCompleted
-
AllerganCompletedCrow's Feet Lines | Lateral Canthus RhytidesBelgium, Canada, United States, United Kingdom
-
AllerganCompletedBenign Prostatic HyperplasiaFrance, Poland, Korea, Republic of, Canada, United States, Germany, Philippines, Czechia
-
AllerganCompletedOveractive BladderPoland, United Kingdom, Portugal, South Africa, Ukraine, Australia, Netherlands, Canada, Singapore, Russian Federation, Germany, Brazil, Austria, Slovakia, Czechia, United States, Taiwan, Italy, France, Belgium, Spain, New Zealand
-
AllerganCompletedOveractive Bladder | Urinary IncontinencePoland, United Kingdom, Belgium, Canada, Russian Federation, United States, Germany, Czechia
-
AllerganCompletedMultiple Sclerosis | Urinary Incontinence | Neurogenic BladderFrance, Poland, Portugal, Belgium, Canada, Russian Federation, Czechia, United States
-
The University of Hong KongFood and Health Bureau, Hong KongCompletedHemifacial Spasm | Blepharospasm | Botulinum Toxins, Type A
-
VA Greater Los Angeles Healthcare SystemIpsenCompleted
-
Evolus, Inc.PPDCompletedGlabellar Frown LinesUnited States
-
Evolus, Inc.CompletedGlabellar Frown LinesUnited States
-
AllerganCompletedOveractive Bladder | Urinary IncontinencePoland, United Kingdom, Germany, Canada, Belgium, United States, Czechia
-
AllerganCompleted
-
AllerganCompletedFacial RhytidesCanada
-
AllerganCompletedFacial RhytidesArgentina
-
AllerganCompletedGlabellar Frown Lines | Facial RhytidesCanada
-
AllerganCompletedGlabellar LinesUnited States, Canada, Brazil, France, Australia
-
AllerganCompletedGlabellar Lines | Crow's Feet Lines | Facial RhytidesGermany, Canada, United States, France
-
AllerganCompletedCrow's Feet Lines | Lateral Canthus RhytidesJapan
-
Boston Urogynecology AssociatesAllerganUnknownMyofascial Pelvic PainUnited States
-
Medy-ToxCompletedGlabellar Frown Lines
-
Medy-ToxCompletedSpasticity, Muscle
-
Icahn School of Medicine at Mount SinaiTerminatedSpinal Cord Injury | Neuropathic Back PainUnited States
-
Medy-ToxCompletedCervical Dystonia
-
Medy-ToxCompletedSpasticityKorea, Republic of
-
Medy-ToxCompletedMuscle Spasticity
-
Medy-ToxCompletedGlabella Line SeverityKorea, Republic of
-
Medy-ToxCompletedSkin AgingKorea, Republic of
-
Medy-ToxCompletedHypertrophy of Masseter MuscleKorea, Republic of
-
Medy-ToxCompletedOveractive BladderKorea, Republic of
-
Medy-ToxCompletedDystonia | Dystonic DisorderKorea, Republic of
-
Evolus, Inc.PPDCompletedGlabellar Frown LinesUnited States
-
Medy-ToxCompleted
-
Evolus, Inc.PPDCompletedA Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001Glabellar Frown LinesUnited States
-
Medy-ToxCompletedMuscle SpasticityKorea, Republic of